« How does PTG-300 work to reduce or eliminate the need for phlebotomy in PV? How does iron deficiency play a role in polycythemia vera? What are the goals of this treatment? Leading MPN expert, Dr. Srdan Verstovsek, from MD Anderson Cancer Center, interviews with David Wallace, discussing early Phase 2 clinical trial results on PTG-300. »
Hepcidin Mimetic PTG-300 Promising Treatment for PV - MPN Voice
Hepcidin Mimetic PTG-300 Promising Treatment for PV
Written by
Manouche
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
PTG-300 Clinical Trial Status
Unfortunately I did not meet parameters for the PTG-300 clinical trial for PV treatment. You have...
NICE Final Guidance on Ruxolitinib for the treatment of Polycythaemia Vera
We are delighted to announce that NICE (the National Institute for Health and Care Excellence) has...
Increasing evidence that Interferons are our best treatment option for PV
Both low risk and high risk PV....
SMC decision regarding Ruxolitinib (Jakavi) for PV patients in Scotland
We are very pleased to announce that following a full submission made to the SMC (Scottish...
Treatment for PV in France
CALR Mutations promising targets for immune therapy ?
Ruxolitinib for PV
HU Resistance/Intolerance Prognostic from Dr Gotlib
